News

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...
The US health secretary is cutting funding for mRNA vaccines because he claims they are less effective than other types – but ...
WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...
Founder of the Medulloblastoma Initiative, Fernando Goldsztein, discusses the new MBI-funded research on experimental mRNA ...
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
Strand Therapeutics' lead asset is STX-001, an intra-tumor self-replicating mRNA therapy that carries a payload expressing ...